2019, October 17-19: An Oasis of Gastrointestinal Pathology
Oct. 17-19, 2019 - Palm Springs, California
15 CME / 15 SAMs
Diagnostic gastrointestinal pathology is experiencing dynamic, fluid changes that require the attention of surgical pathologists who specialize in this area or who sign-out biopsies from the GI tract and liver. There are updates in the AJCC staging of mucinous neoplasms of the appendix and conceptual changes in interpreting appendectomy samples containing luminal and extra-appendiceal mucin; there is confusion about the diagnosis and outcome of so-called goblet cell carcinoid, and a new classification scheme is available; Barrett’s esophagus is often over-diagnosed but a new method informs separation of reactive changes from low-grade and indefinite dysplasia; spindle cell tumors can be separated morphologically and by their molecular features; overlapping patterns of injury are encountered in disease and iatrogenic conditions, but can be separated; liver pathology has become more challenging in the context of treatment for Hepatitis C; certain infections may be mistaken for inflammatory disease, requiring criteria for identification and diagnosis. This faculty derived from the Rodger C. Haggitt Gastrointestinal Pathology Society (GIPS) is poised to provide the latest information in these challenging areas in a unique mentoring environment.
- Recognize several types of appendiceal lesions and their biologic potential
- Compare features of several types of gastrointestinal and hepatic lesions to their mimics
- Understand the morphology and biology of several types of gastrointestinal spindle cell lesions
- Comprehend key features that separate reactive columnar cell proliferations from dysplasia
- Assess endoscopic resection samples
- Elizabeth A. Montgomery, MD
Johns Hopkins University
- Teri A. Longacre, MD
- Joseph Misdraji, MD
Harvard Medical School
- Meredith Pittman, MD, MSCI
Weill Cornell Medicine
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States and Canadian Academy of Pathology and the Gastrointestinal Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC).
Physicians can earn a maximum of 15 SAM credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
Cancellations will be assessed an administrative charge of 25% of the total registration fee. There will be no refunds for cancellations within 14 days of the event. The Academy is not responsible for travel expenses incurred as a result of an event cancellation.